BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34958503)

  • 1. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
    Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
    Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER; Lockwood CM; Stohr BA; Vargas SO; Sheridan R; Black JO; Rajaram V; Laetsch TW; Davis JL
    Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney.
    Tan SY; Al-Ibraheemi A; Ahrens WA; Oesterheld JE; Fanburg-Smith JC; Liu YJ; Spunt SL; Rudzinski ER; Coffin C; Davis JL
    Histopathology; 2022 Mar; 80(4):698-707. PubMed ID: 34843129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
    Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
    Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).
    Atiq MA; Davis JL; Hornick JL; Dickson BC; Fletcher CDM; Fletcher JA; Folpe AL; Mariño-Enríquez A
    Mod Pathol; 2021 Jan; 34(1):95-103. PubMed ID: 32669612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm.
    Wong DD; Vargas AC; Bonar F; Maclean F; Kattampallil J; Stewart C; Sulaiman B; Santos L; Gill AJ
    Pathology; 2020 Jun; 52(4):401-409. PubMed ID: 32278476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
    Surrey LF; Davis JL
    Cancer Genet; 2022 Jan; 260-261():6-13. PubMed ID: 34794069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
    Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
    J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
    Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
    J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.
    Misove A; Vicha A; Zapotocky M; Malis J; Balko J; Nemeckova T; Szabova J; Kyncl M; Novakova-Kodetova D; Stolova L; Jencova P; Broz P; Krskova L
    Genes Chromosomes Cancer; 2021 Dec; 60(12):837-840. PubMed ID: 34378283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
    Hung YP; Fletcher CDM; Hornick JL
    Histopathology; 2018 Oct; 73(4):634-644. PubMed ID: 29863809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile NTRK-associated Mesenchymal Tumors.
    Davis JL; Lockwood CM; Albert CM; Tsuchiya K; Hawkins DS; Rudzinski ER
    Pediatr Dev Pathol; 2018; 21(1):68-78. PubMed ID: 28683589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement.
    El Demellawy D; Cundiff CA; Nasr A; Ozolek JA; Elawabdeh N; Caltharp SA; Masoudian P; Sullivan KJ; de Nanassy J; Shehata BM
    Pathology; 2016 Jan; 48(1):47-50. PubMed ID: 27020209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript.
    Hermann AL; Lemelle L; Pierron G; Gauthier A; Nicolas N; Cardoen L; Moalla S; Petit P; Morel B; Ducou Le Pointe H; Hassani A; Fréneaux P; Guillemot D; Carton M; Corradini N; Rome A; Castex MP; Defachelles AS; Schleiermacher G; Berlanga P; Delattre O; Orbach D; Brisse HJ
    Br J Radiol; 2024 Mar; 97(1156):734-743. PubMed ID: 38327010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.
    Rubin BP; Chen CJ; Morgan TW; Xiao S; Grier HE; Kozakewich HP; Perez-Atayde AR; Fletcher JA
    Am J Pathol; 1998 Nov; 153(5):1451-8. PubMed ID: 9811336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors.
    Davis JL; Lockwood CM; Stohr B; Boecking C; Al-Ibraheemi A; DuBois SG; Vargas SO; Black JO; Cox MC; Luquette M; Turpin B; Szabo S; Laetsch TW; Albert CM; Parham DM; Hawkins DS; Rudzinski ER
    Am J Surg Pathol; 2019 Apr; 43(4):435-445. PubMed ID: 30585824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
    Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions.
    Kojima N; Mori T; Motoi T; Kobayashi E; Yoshida M; Yatabe Y; Ichikawa H; Kawai A; Yonemori K; Antonescu CR; Yoshida A
    Mod Pathol; 2023 Apr; 36(4):100083. PubMed ID: 36788089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
    Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms.
    Warmke LM; Al-Ibraheemi A; Wang L; Parham D; Rudzinski ER; Stohr BA; Miles C; Habeeb O; Davis JL
    Genes Chromosomes Cancer; 2023 Nov; 62(11):641-647. PubMed ID: 37265193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.